Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Journal of Translational Medicine|September 29, 2011
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patientsMariacarmela Santarpia, Ignacio Magri, Maria Sanchez-Ronco, et al.
Oncotarget|June 23, 2018
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancerTeresa Morán, Eudald Felip, Joaquim Bosch-Barrera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 31, 2023
Difficulties on the access to innovative targeted therapies for lung cancer in SpainVirginia Calvo, Carlos Camps, Enric Carcereny, et al.
Oncotarget|May 10, 2019
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancerTeresa Morán, Eudald Felip, Joaquim Bosch-Barrera, et al.
JCO Precision Oncology|January 7, 2022
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung CancerRamon Palmero, Alvaro Taus, Santiago Viteri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutationsNiki Karachaliou, Carlota Costa, Ana Gimenez-Capitan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2022
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung CancerRoy S Herbst, Margarita Majem, Fabrice Barlesi, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 2, 2023
Integration of Clinical Information and Imputed Aneuploidy Scores to Enhance Relapse Prediction in Early Stage Lung Cancer PatientsMohan Timilsina, Samuele Buosi, Dirk Fey, et al.
Molecular Oncology|February 28, 2023
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLCCaterina Carbonell, Joan Frigola, Nuria Pardo, et al.
JAMA Network Open|July 15, 2025
Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer: Update From the COAST Randomized Clinical TrialCharu Aggarwal, Alex Martinez-Marti, Margarita Majem, et al.
Pageof 11